Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Riccardo Alberto Campora"'
Publikováno v:
Qeios.
Publikováno v:
Qeios.
Background: Osteonecrosis of the Jaw (ONJ) - related to Bisphosphonates (BPs), denosumab, and other drugs - is a bone disease, that should be evaluated not only on base of clinical features (bone exposure and other signs or symptoms) but also by imag
Impact of Osteonecrosis of Jaw (ONJ) on ten year experience of a multidisciplinary osteoncology team
Autor:
Iolanda De Martino, kristijan zoccola, Roberta Libener, Andrea Barbanera, Manuela Alessio, Ivan Gallesio, Vittorio Fusco, Luigi Tommasi, Antonella Fasciolo, Giovanna Bellotti, Paola Franzone, Riccardo Alberto Campora
The Osteonecrosis of the Jaw (ONJ) is a bone disease only recently recognized (since 2003) and reported in association with use of bisphosphonates (BPs), denosumab, and other drugs mostly in patients with cancer, myeloma, and osteoporosis. Not all cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4adf1b0c9399cb3a93fa65a18480e41a
https://doi.org/10.32388/1vkts1
https://doi.org/10.32388/1vkts1
Autor:
Iolanda De Martino, Paola Brigo, Daniela Tartara, Manuela Alessio, Riccardo Alberto Campora, Vittorio Fusco, Antonella Fasciolo, Maura Rossi
PATIENTS AT RISK OF OSTEONECROSIS OF THE JAW (ONJ) INCLUDE MOSTLY CANCER AND MYELOMA PATIENTS RECEIVING ANTIRESORPTIVE TREATMENTS (BISPHOSPHONATES AND DENOSUMAB) WITH/WITHOUT BIOLOGICAL AGENTS, BUT ALSO PATIENTS WITH OSTEOPOROSIS AND RHEUMATOLOGIC DI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bcd2e44ae4e76b5d02e6dcad05865907
https://doi.org/10.32388/0qk8e2
https://doi.org/10.32388/0qk8e2